CHARLES RIVER LABORATORIES INTERNATIONAL, INC. acquired K.F. (Cambodia) Ltd for $510.0 million ($335.0 million up-front, $175.0 million deferred), a transaction completed in January 2026, structured as asset purchase (cash and Credit Facility proceeds).
K.F. (Cambodia) Ltd operates in DSA. Leading supplier of non-human primates (NHPs) located in Cambodia; acquisition of certain assets to vertically integrate the DSA supply chain.
Secures a vertically integrated internal supply of NHPs for Charles River's Discovery and Safety Assessment (DSA) business.
Advisory firms were not disclosed for this transaction.